Jefferies Reiterates Buy, Raises Price Target On Medtronic Following Very Good F3Q - Medtronic (NYSE:MDT)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

In a report published Wednesday, Jefferies analyst Raj Denhoy reiterated a Buy rating on

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Medtronic PLC

(NYSE: MDT), and raised the price target from $83.00 to $89.00.In the report, Jefferies noted, "MDT posted a very good F3Q, highlighted by: strength in CRDM, where the US quadpole launch is yielding ICD share capture from STJ and Linq continues to be a star performer; CoreValve, where TAVR market growth remains robust; and improvement in Spine. The revenue growth outlook and cost synergy targets of the Covidien deal are intact. Reiterate Buy."Medtronic closed on Tuesday at $78.07.